Inovio Pharmaceuticals, Inc. (0A43.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 07:07PM BST. Market open.
| Previous close | 10.59 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 28,855 |
| Market cap | N/A |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Insider Monkey
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript March 6, 2024 Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
- Thomson Reuters StreetEvents
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
Q4 2023 Inovio Pharmaceuticals Inc Earnings Call
© 2024 Yahoo. All rights reserved.